Addressing the public health burden of respiratory viruses: the Battle against Respiratory Viruses (BRaVe) Initiative
Addressing the public health burden of respiratory viruses: the Battle against Respiratory Viruses (BRaVe) Initiative
复制标题
DOI：
10.2217/fvl.13.85
复制
发表时间：
2013-10-01
期刊：
影响因子：
3.1
通讯作者：
Hayden, Frederick G.
中科院分区：
文献类型：
--
作者：
Legand, Anais;Briand, Sylvie;Hayden, Frederick G.
鉴于全球范围内呼吸道病毒感染的巨大估计负担，存在大量研究优先事项，以便更好地了解其在不同人群和资源环境中的流行病学，发病机制，预防和临床管理。针对非流感呼吸道病毒感染的新疗法和特异性疫苗可以在降低与这些频繁感染相关的发病率和死亡率方面提供巨大益处，并为应对新出现的威胁提供基础。BRaVe倡议是世卫组织领导的一项新的努力，旨在促进关于预防和治疗医学上重要的呼吸道病毒感染战略的多学科研究，目的是及时将科学进步和技术创新纳入公共卫生实践。
Given the enormous estimated burden of respiratory virus infections worldwide, a substantial number of research priorities exist in order to better understand their epidemiology, pathogenesis, prevention and clinical management across different populations and resource settings. New therapeutics and specific vaccines for noninfluenza respiratory virus infections could provide enormous benefits in reducing the morbidity and mortality associated with these frequent infections and provide the foundation for responding to newly emerging threats. The BRaVe Initiative is a new WHO-led effort to catalyze multidisciplinary research on strategies to prevent and treat medically important respiratory virus infections with the goal of timely integration of scientific advances and technical innovations into public health practice.